IP Library › Granted Patent US 12,403,334
Granted Patent B2
US 12,403,334 · App. 17/249,638 · Granted Sep 2, 2025

Low intensity ultrasound therapy

Inventors: Joseph Kost (Omer, IL); Aharon (Roni) Azagury (Kiryat Gat, IL); Yana Yudilevich (Beer Sheva, IL); Eden Bergman (Machane Adi, IL); Tamar Traitel (Beer Sheva, IL); Rivka Goldbart (Lehavim, IL); Itay Rousso (Even Yehuda, IL); Moshe Elkabets (Kibbutz Beit Kama, IL)
Assignee: B G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
A61N7/022A61N2007/0004A61N2007/0073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,403,334
App. No.
17/249,638
Granted
Sep 2, 2025
Kind
B2
Abstract

Provided herein methods for treating a subject suffering from a disease or a disorder associated with hyperproliferating cells, by irradiating the cells with low-frequency ultrasound at an intensity that is either below the cavitational threshold intensity for the ultrasound frequency, or is characterized by a low-frequency mechanical index below 2.5. The methods may further comprise determining an elasticity value of the cells, and adjusting the ultrasound intensity accordingly.

Claims (7)

1. A method of treating a subject suffering from a disease or a disorder associated with hyperproliferating cells, said method comprising non-invasively irradiating a tissue comprising said hyperproliferating cells in said subject with ultrasound, said ultrasound having a frequency between 20 and 200 kHz, at an intensity between 0.5 and 100 W/cm 2 , provided that the intensity is characterized by a low-frequency mechanical index of between 1 and 2.5, wherein said intensity produces a mechanical index lower than 2.5, and wherein said method comprises evaluating a mechanical stiffness of said hyperproliferating cells, prior to said irradiating, and adjusting said intensity based on said evaluating.

2. The method according to claim 1 , wherein said evaluating comprises obtaining a ratio between elasticity values of said hyperproliferating cells and healthy tissue cells obtained from a vicinity of said hyperproliferating cells.

3. The method according to claim 2 , wherein said elasticity values are obtained by determining Young's modulus of said hyperproliferating cells in a sample obtained from said subject.

4. The method according to claim 2 , wherein said elasticity value of said healthy tissue cells is determined based on reference values of Young's modulus characteristic of said healthy tissue cells.

5. The method according to claim 1 , wherein said evaluating is performed by atomic force microscopy.

6. The method according to claim 1 , wherein said evaluating is performed by confocal microscopy with F-actin staining.

7. The method according to claim 1 , wherein said adjusting of the intensity comprises determining a maximal intensity producing a mechanical index of 2.5, and administering the ultrasound at an intensity of between 1 and 40% of the maximum intensity if a ratio of elasticity values is between 0.01 and 0.15, administering ultrasound at an intensity of between 10 and 80% of the maximum intensity if the ratio of elasticity values is between 0.15 and 0.35, and administering ultrasound at an intensity of between 25 and 100% of the maximum intensity if the ratio of elasticity values is between 0.35 and 0.7.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2021
From: KOST, JOSEPH; AZAGURY, AHARON; YUDILEVICH, YANA; BERGMAN, EDEN; TRAITEL, TAMAR; GOLDBART, RIVKA; ROUSSO, ITAY; ELKABETS, MOSHE
To: B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
Reel/Frame 057900/0282 →
Continuity (3)
Continuation In Part 14198701 · Mar 6, 2014
Provisional Application 61773169 · Mar 6, 2013
Related Publication 20210213307A1 · Jul 15, 2021
References Cited (22)
US 6589173B1 · Mitragotri · 2003 [cited by applicant]
US 7481781B2 · Craig et al. · 2009 [cited by applicant]
US 20020004052A1 · Berd et al. · 2002 [cited by applicant]
US 20020192221A1 · Roach · 2002 [cited by examiner]
US 20040187876A1 · Myhr · 2004 [cited by examiner]
US 20050054958A1 · Hoffmann · 2005 [cited by applicant]
US 20070088345A1 · Larson et al. · 2007 [cited by applicant]
US 20080056937A1 · Cordemans de Meulenaer et al. · 2008 [cited by applicant]
US 20080071312A1 · Ridgway · 2008 [cited by applicant]
US 20100092424A1 · Sanghvi et al. · 2010 [cited by applicant]
US 20110178441A1 · Tyler · 2011 [cited by applicant]
US 20130129799A1 · Shibaguchi · 2013 [cited by examiner]
US 20130131432A1 · Kline · 2013 [cited by applicant]
US 20150306429A1 · Towe · 2015 [cited by examiner]
WO WO2006051542 · 2006 [cited by applicant]
http://physicaltherapyweb.com/therapeutic-ultrasound, retrieved Nov. 7, 2016. [cited by applicant]
Healing sound: the use of ultrasound in drug delivery and other therapeutic applications, by Sarnir Mitragotri, published in Nature Reviews—Drug Discovery, vol. 4, Mar. 2005, pp. 255-260. [cited by applicant]
Kennedy, “High-intensity focused ultrasound in the treatment of solid tumors,” Nature Reviews: Cancer, vol. 5, Mar. 18, 2005, pp. 321-327. [cited by applicant]
Sponer, “Dependence of the Cavitation Threshold on the Ultrasonic Frequency,” Czech J. Phys., vol. 40: 1123-1132 (1990). [cited by applicant]
Kenneth S. Suslick: Ultrasonic-Its Chemical, Physical and Biological Effects, NY VCH publications, pp. 20 and 311, 1988. [cited by applicant]
Ahmadi et al., Progress in Biophysics and Molecular Biology 108 (2012), “Bio-effects and safety of low-intensity, low-frequency ultrasonic exposure,” pp. 119-138, journal homepage: www.elsevier.com/locate/pbiomolbio. [cited by applicant]
Hedrick et al., “An Overview of Thermal and Mechanical Acoustic Output Indices,” JDMS 9; pp. 228-235; Sep./Oct. 1993. [cited by applicant]